TY - JOUR
T1 - Schistosome Infection is Associated with High-Risk Human Papillomavirus Persistence, Together with Altered Cervicovaginal Microbiota
AU - Mukerebe, Crispin
AU - Cordeiro, Alexandra A
AU - Aristide, Christine
AU - Colombe, Soledad
AU - Bullington, Brooke W
AU - Kalluvya, Samuel
AU - van Dam, Govert J
AU - de Dood, Claudia J
AU - Corstjens, Paul L A M
AU - Maganga, Jane K
AU - Changalucha, John M
AU - Namkinga, Lucy A
AU - Makene, Victor Anacletus
AU - Lee, Myung Hee
AU - Downs, Jennifer A
N1 - FTX: Abonnement
PY - 2025
Y1 - 2025
N2 - Schistosoma haematobium infection may impair female genital mucosal antiviral defense. We sought to determine whether women with S. haematobium infection had higher odds of high-risk human papillomavirus (HR-HPV) persistence, a pre-requisite to cervical cancer. We also examined cervicovaginal dysbiosis, which has been linked to HR-HPV persistence and schistosome infection. In 96 Tanzanian women with baseline and 9-12-month follow-up samples, we performed HPV genotyping, schistosome antigen quantification, and 16S rRNA sequencing. Both S. haematobium (Odds ratio (OR): 4.7 [1.3-16.5], p=0.017) and Gardnerella-dominant microbiome (p=0.049) were associated with HR-HPV persistence, suggesting these factors may contribute to high cervical cancer rates in Africa.
AB - Schistosoma haematobium infection may impair female genital mucosal antiviral defense. We sought to determine whether women with S. haematobium infection had higher odds of high-risk human papillomavirus (HR-HPV) persistence, a pre-requisite to cervical cancer. We also examined cervicovaginal dysbiosis, which has been linked to HR-HPV persistence and schistosome infection. In 96 Tanzanian women with baseline and 9-12-month follow-up samples, we performed HPV genotyping, schistosome antigen quantification, and 16S rRNA sequencing. Both S. haematobium (Odds ratio (OR): 4.7 [1.3-16.5], p=0.017) and Gardnerella-dominant microbiome (p=0.049) were associated with HR-HPV persistence, suggesting these factors may contribute to high cervical cancer rates in Africa.
UR - https://www.webofscience.com/wos/woscc/full-record/WOS:001577974700001
U2 - 10.1093/infdis/jiaf447
DO - 10.1093/infdis/jiaf447
M3 - Article
C2 - 40842278
SN - 0022-1899
JO - Journal of Infectious Diseases
JF - Journal of Infectious Diseases
M1 - jiaf447
ER -